New anxiety drug tested on brain and behavior
Disease control
Not yet recruiting
This study is testing a single dose of an investigational drug called SYT-510 for people with generalized anxiety disorder (GAD). It aims to see how the drug affects brain activity, anxiety-related behaviors, and feelings of dread in 24 unmedicated adults. The main goal is to gat…
Phase: PHASE2 • Sponsor: Synendos Therapeutics AG • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC